Related Experiment Video
Updated: Mar 12, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
[Smoking parental as risk factor for the development of Neonatal Respiratory Distress Syndrome]
Mario Alberto Arrieta-Mendoza1, Arnoldo Salas-Delgado2
1Departamento de Pediatría, Hospital Regional Monterrey ISSSTE, Monterrey, N.L., México.
Abstract:
The Respiratory Distress Syndrome (RDS) is one of the most frequent pathologies in the premature neonates and a major cause of morbidity and mortality. The objective of this study was to determine the association between parental smoking and the development of this syndrome. This study was an observational, longitudinal, retrospective, analytical, prolective type, with the neonates in the Neonatal Intensive Care Unit (NICU) of the Hospital Regional Monterrey (HRMI), who developed RDS (cases) and those that do not (controls), during the period January 2012 - April 2015, in both groups were determined the smoking habits of the father and the statistical analysis using SPSS (v. 14). The total sample was 85 RN, of which 46 developed SDR and 39 didn´t develop it, predominantly the genre male (56%). Seventy per cent of the group of parents who denied smoking, their children developed SDR, while 64% of parents who reported smoking, their children did not manifest this syndrome. The p-value was of 0.002, OR = 0.245, with 0.099 to 0.607 range.
Conclusion:
Parental smoking isn´t a risk factor for the development of RDS in the neonates, it could be considered a protective factor.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
08:58Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Pulmonary Cycle: Exhalation
Breathing
Asthma-I: Introduction
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Other Pulmonary Disorders